Multi-omics and single-cell analysis reveals machine learning-based pyrimidine metabolism-related signature in the prognosis of patients with lung adenocarcinoma
International Journal of Medical Sciences · 2025
DOI: 10.7150/ijms.107694 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Medical Sciences, 2025. Verfasst von Tong Hu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Pyrimidines, Machine Learning, Lung Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
- Department of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
- Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China.
Zitieren
APA
Hu, T., Shi, R., Xu, Y., Xu, T., Fang, Y., Gu, Y., Zhou, Z., & Shu, Y. (2025). Multi-omics and single-cell analysis reveals machine learning-based pyrimidine metabolism-related signature in the prognosis of patients with lung adenocarcinoma. International Journal of Medical Sciences. https://doi.org/10.7150/ijms.107694
Vancouver
Hu T, Shi R, Xu Y, Xu T, Fang Y, Gu Y, et al. Multi-omics and single-cell analysis reveals machine learning-based pyrimidine metabolism-related signature in the prognosis of patients with lung adenocarcinoma. International Journal of Medical Sciences. 2025. doi:10.7150/ijms.107694
BibTeX
@article{Hu2025,
author = {Hu, Tong and Shi, Run and Xu, Yangyue and Xu, Tingting and Fang, Yuan and Gu, Yunru and Zhou, Zhaokai and Shu, Yongqian},
title = {Multi-omics and single-cell analysis reveals machine learning-based pyrimidine metabolism-related signature in the prognosis of patients with lung adenocarcinoma},
journal = {International Journal of Medical Sciences},
year = {2025},
doi = {10.7150/ijms.107694}
}
EUVIMED